ArticleTranslational cancer research2025

Warfarin and bevacizumab suppress tumor progression in pancreatic ductal adenocarcinoma by targeting EGFR-PI3K-Akt signaling: inhibition of proliferation/migration and apoptosis induction.

Jingjing Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.